UnitedHealth Group Incorporated (NYSE:UNH) had its price target boosted by Jefferies Group LLC from $215.00 to $225.00 in a report published on Friday morning. They currently have a buy rating on the healthcare conglomerate’s stock.
Several other brokerages have also recently weighed in on UNH. Cantor Fitzgerald restated an overweight rating and issued a $208.00 price target on shares of UnitedHealth Group in a research report on Friday, July 21st. ValuEngine upgraded shares of UnitedHealth Group from a hold rating to a buy rating in a research report on Friday, September 1st. Zacks Investment Research cut shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an outperform rating and set a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, BidaskClub lowered shares of UnitedHealth Group from a strong-buy rating to a buy rating in a research note on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has an average rating of Buy and an average target price of $204.02.
Shares of UnitedHealth Group (UNH) opened at 193.20 on Friday. The company has a market cap of $186.80 billion, a price-to-earnings ratio of 23.21 and a beta of 0.63. UnitedHealth Group has a 52-week low of $133.03 and a 52-week high of $200.76. The stock has a 50 day moving average of $196.56 and a 200 day moving average of $184.87.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.96 earnings per share. On average, equities research analysts expect that UnitedHealth Group will post $9.87 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Stock Observer and is owned by of Stock Observer. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thestockobserver.com/2017/10/17/unitedhealth-group-incorporated-unh-price-target-increased-to-225-00-by-analysts-at-jefferies-group-llc.html.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s payout ratio is 35.13%.
In related news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 76,174 shares of company stock worth $14,981,909. 0.89% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Honeywell International Inc. acquired a new stake in UnitedHealth Group during the first quarter worth about $35,262,000. Schwab Charles Investment Management Inc. grew its stake in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after buying an additional 183,401 shares in the last quarter. Suntrust Banks Inc. grew its stake in shares of UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after buying an additional 20,541 shares in the last quarter. Factory Mutual Insurance Co. grew its stake in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after buying an additional 72,000 shares in the last quarter. Finally, Shell Asset Management Co. grew its stake in shares of UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock valued at $29,156,000 after buying an additional 1,254 shares in the last quarter. Hedge funds and other institutional investors own 86.11% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.